Your browser doesn't support javascript.
loading
Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy.
Ma, Youzhao; Zhu, Mingda; Zhang, Jingyang; Lv, Minhao; Chen, Xiuchun; Liu, Zhenzhen.
Afiliación
  • Ma Y; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Zhu M; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Zhang J; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Lv M; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Chen X; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Liu Z; Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Cancer Res Treat ; 55(4): 1210-1221, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37024094
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación:
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: